Fakprapai Wuttidej, Wattanakrai Penpun
Division of Dermatology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Case Rep Dermatol. 2019 May 21;11(2):130-139. doi: 10.1159/000499525. eCollection 2019 May-Aug.
Acquired hemophilia A (AHA) is a rare autoimmune disorder with high morbidity and mortality. It results from the development of circulating autoantibodies against factor VIII. AHA can be seen in association with autoimmune vesiculobullous diseases, autoimmune diseases, malignancy, pregnancy, and medications. We report a 68-year-old Thai woman diagnosed and treated for bullous pemphigoid (BP) for 11 months who recently presented with a 3-day history of extensive hemorrhagic bullae and large intra-oral buccal hematoma. Laboratory investigations confirmed a prolonged activated partial thromboplastin time, a low factor VIII level, a high factor VIII inhibitor level, and elevated anti-BPAG180 and anti-BPAG230 titers, confirming the diagnosis of BP associated with AHA. Immunosuppressive therapy with systemic corticosteroids and cyclophosphamide combined with bypassing agents for bleeding control resulted in significant clinical improvement and subsequent negative antibody levels. There was no recurrence after a 7-month follow-up period. Due to life-threatening bleeding in severe AHA cases, early diagnosis and effective treatment in this condition are essential.
获得性血友病A(AHA)是一种罕见的自身免疫性疾病,发病率和死亡率都很高。它是由针对凝血因子VIII的循环自身抗体的产生所导致的。AHA可见于自身免疫性水疱大疱性疾病、自身免疫性疾病、恶性肿瘤、妊娠及药物相关情况。我们报告了一名68岁的泰国女性,她被诊断为大疱性类天疱疮(BP)并接受治疗11个月,最近出现了3天的广泛出血性水疱和口腔内颊部大血肿病史。实验室检查证实活化部分凝血活酶时间延长、凝血因子VIII水平降低、凝血因子VIII抑制物水平升高,以及抗BPAG180和抗BPAG230滴度升高,从而确诊为与AHA相关的BP。采用全身糖皮质激素和环磷酰胺进行免疫抑制治疗,并联合使用旁路制剂控制出血,使临床症状得到显著改善,随后抗体水平转阴。经过7个月的随访期,未出现复发情况。由于严重AHA病例存在危及生命的出血情况,因此对此病进行早期诊断和有效治疗至关重要。